Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Expands By 150.0%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 6,000 shares, a growth of 150.0% from the March 15th total of 2,400 shares. Based on an average trading volume of 10,600 shares, the days-to-cover ratio is presently 0.6 days.

Lexaria Bioscience Price Performance

Shares of Lexaria Bioscience stock traded up $0.01 during trading on Tuesday, reaching $0.37. 10,946 shares of the company’s stock were exchanged, compared to its average volume of 12,054. The firm’s 50-day moving average price is $0.30 and its 200 day moving average price is $0.57. Lexaria Bioscience has a 1-year low of $0.16 and a 1-year high of $2.00.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.